Global Placental Stem Cell Therapy for Neurological Disorders Supply, Demand and Key Producers, 2023-2029

Description

The global Placental Stem Cell Therapy for Neurological Disorders market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.

Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson's disease, Alzheimer's, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.

This report studies the global Placental Stem Cell Therapy for Neurological Disorders demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Placental Stem Cell Therapy for Neurological Disorders, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Placental Stem Cell Therapy for Neurological Disorders that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Placental Stem Cell Therapy for Neurological Disorders total market, 2018-2029, (USD Million)
Global Placental Stem Cell Therapy for Neurological Disorders total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Placental Stem Cell Therapy for Neurological Disorders total market, key domestic companies and share, (USD Million)
Global Placental Stem Cell Therapy for Neurological Disorders revenue by player and market share 2018-2023, (USD Million)
Global Placental Stem Cell Therapy for Neurological Disorders total market by Type, CAGR, 2018-2029, (USD Million)
Global Placental Stem Cell Therapy for Neurological Disorders total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Placental Stem Cell Therapy for Neurological Disorders market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mesoblast, Pleurite Therapeutic, Athersys, Cordlife India, Life Cell, Cryo-Cell, CBR Systems, ReNeuron Group and Cynata, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Placental Stem Cell Therapy for Neurological Disorders market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Placental Stem Cell Therapy for Neurological Disorders Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Placental Stem Cell Therapy for Neurological Disorders Market, Segmentation by Type
    Allogeneic Placental Stem Cell Therapy
    Autologous Placental Stem Cell Therapy

Global Placental Stem Cell Therapy for Neurological Disorders Market, Segmentation by Application
    Hospitals and Specialist Clinics
    Clinical Research Institute

Companies Profiled:
    Mesoblast
    Pleurite Therapeutic
    Athersys
    Cordlife India
    Life Cell
    Cryo-Cell
    CBR Systems
    ReNeuron Group
    Cynata
    Celularity
    Americord Registry
    ReeLabs
    Mesoblast

Key Questions Answered
1. How big is the global Placental Stem Cell Therapy for Neurological Disorders market?
2. What is the demand of the global Placental Stem Cell Therapy for Neurological Disorders market?
3. What is the year over year growth of the global Placental Stem Cell Therapy for Neurological Disorders market?
4. What is the total value of the global Placental Stem Cell Therapy for Neurological Disorders market?
5. Who are the major players in the global Placental Stem Cell Therapy for Neurological Disorders market?

Table of Contents

1 Supply Summary
    1.1 Placental Stem Cell Therapy for Neurological Disorders Introduction
    1.2 World Placental Stem Cell Therapy for Neurological Disorders Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Placental Stem Cell Therapy for Neurological Disorders Total Market by Region (by Headquarter Location)
        1.3.1 World Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
        1.3.3 China Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
        1.3.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
        1.3.5 Japan Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
        1.3.6 South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
        1.3.7 ASEAN Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
        1.3.8 India Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Placental Stem Cell Therapy for Neurological Disorders Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Placental Stem Cell Therapy for Neurological Disorders Major Market Trends

2 Demand Summary
    2.1 World Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.2 World Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region
        2.2.1 World Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2018-2023)
        2.2.2 World Placental Stem Cell Therapy for Neurological Disorders Consumption Value Forecast by Region (2024-2029)
    2.3 United States Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.4 China Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.5 Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.6 Japan Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.7 South Korea Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.8 ASEAN Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)
    2.9 India Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029)

3 World Placental Stem Cell Therapy for Neurological Disorders Companies Competitive Analysis
    3.1 World Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Placental Stem Cell Therapy for Neurological Disorders in 2022
        3.2.3 Global Concentration Ratios (CR8) for Placental Stem Cell Therapy for Neurological Disorders in 2022
    3.3 Placental Stem Cell Therapy for Neurological Disorders Company Evaluation Quadrant
    3.4 Placental Stem Cell Therapy for Neurological Disorders Market: Overall Company Footprint Analysis
        3.4.1 Placental Stem Cell Therapy for Neurological Disorders Market: Region Footprint
        3.4.2 Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Type Footprint
        3.4.3 Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Placental Stem Cell Therapy for Neurological Disorders Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Placental Stem Cell Therapy for Neurological Disorders Consumption Value Comparison
        4.2.1 United States VS China: Placental Stem Cell Therapy for Neurological Disorders Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Placental Stem Cell Therapy for Neurological Disorders Companies and Market Share, 2018-2023
        4.3.1 United States Based Placental Stem Cell Therapy for Neurological Disorders Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue, (2018-2023)
    4.4 China Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue and Market Share, 2018-2023
        4.4.1 China Based Placental Stem Cell Therapy for Neurological Disorders Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue, (2018-2023)
    4.5 Rest of World Based Placental Stem Cell Therapy for Neurological Disorders Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Placental Stem Cell Therapy for Neurological Disorders Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Placental Stem Cell Therapy for Neurological Disorders Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Allogeneic Placental Stem Cell Therapy
        5.2.2 Autologous Placental Stem Cell Therapy
    5.3 Market Segment by Type
        5.3.1 World Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2018-2023)
        5.3.2 World Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2024-2029)
        5.3.3 World Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Placental Stem Cell Therapy for Neurological Disorders Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and Specialist Clinics
        6.2.2 Clinical Research Institute
    6.3 Market Segment by Application
        6.3.1 World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2018-2023)
        6.3.2 World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2024-2029)
        6.3.3 World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Mesoblast
        7.1.1 Mesoblast Details
        7.1.2 Mesoblast Major Business
        7.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.1.4 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Mesoblast Recent Developments/Updates
        7.1.6 Mesoblast Competitive Strengths & Weaknesses
    7.2 Pleurite Therapeutic
        7.2.1 Pleurite Therapeutic Details
        7.2.2 Pleurite Therapeutic Major Business
        7.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.2.4 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Pleurite Therapeutic Recent Developments/Updates
        7.2.6 Pleurite Therapeutic Competitive Strengths & Weaknesses
    7.3 Athersys
        7.3.1 Athersys Details
        7.3.2 Athersys Major Business
        7.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.3.4 Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Athersys Recent Developments/Updates
        7.3.6 Athersys Competitive Strengths & Weaknesses
    7.4 Cordlife India
        7.4.1 Cordlife India Details
        7.4.2 Cordlife India Major Business
        7.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.4.4 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Cordlife India Recent Developments/Updates
        7.4.6 Cordlife India Competitive Strengths & Weaknesses
    7.5 Life Cell
        7.5.1 Life Cell Details
        7.5.2 Life Cell Major Business
        7.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.5.4 Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Life Cell Recent Developments/Updates
        7.5.6 Life Cell Competitive Strengths & Weaknesses
    7.6 Cryo-Cell
        7.6.1 Cryo-Cell Details
        7.6.2 Cryo-Cell Major Business
        7.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.6.4 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Cryo-Cell Recent Developments/Updates
        7.6.6 Cryo-Cell Competitive Strengths & Weaknesses
    7.7 CBR Systems
        7.7.1 CBR Systems Details
        7.7.2 CBR Systems Major Business
        7.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.7.4 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 CBR Systems Recent Developments/Updates
        7.7.6 CBR Systems Competitive Strengths & Weaknesses
    7.8 ReNeuron Group
        7.8.1 ReNeuron Group Details
        7.8.2 ReNeuron Group Major Business
        7.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.8.4 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 ReNeuron Group Recent Developments/Updates
        7.8.6 ReNeuron Group Competitive Strengths & Weaknesses
    7.9 Cynata
        7.9.1 Cynata Details
        7.9.2 Cynata Major Business
        7.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.9.4 Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Cynata Recent Developments/Updates
        7.9.6 Cynata Competitive Strengths & Weaknesses
    7.10 Celularity
        7.10.1 Celularity Details
        7.10.2 Celularity Major Business
        7.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.10.4 Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Celularity Recent Developments/Updates
        7.10.6 Celularity Competitive Strengths & Weaknesses
    7.11 Americord Registry
        7.11.1 Americord Registry Details
        7.11.2 Americord Registry Major Business
        7.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.11.4 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Americord Registry Recent Developments/Updates
        7.11.6 Americord Registry Competitive Strengths & Weaknesses
    7.12 ReeLabs
        7.12.1 ReeLabs Details
        7.12.2 ReeLabs Major Business
        7.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.12.4 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 ReeLabs Recent Developments/Updates
        7.12.6 ReeLabs Competitive Strengths & Weaknesses
    7.13 Mesoblast
        7.13.1 Mesoblast Details
        7.13.2 Mesoblast Major Business
        7.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Services
        7.13.4 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Mesoblast Recent Developments/Updates
        7.13.6 Mesoblast Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Placental Stem Cell Therapy for Neurological Disorders Industry Chain
    8.2 Placental Stem Cell Therapy for Neurological Disorders Upstream Analysis
    8.3 Placental Stem Cell Therapy for Neurological Disorders Midstream Analysis
    8.4 Placental Stem Cell Therapy for Neurological Disorders Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Placental Stem Cell Therapy for Neurological Disorders Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Placental Stem Cell Therapy for Neurological Disorders Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Placental Stem Cell Therapy for Neurological Disorders Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Placental Stem Cell Therapy for Neurological Disorders Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Placental Stem Cell Therapy for Neurological Disorders Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Placental Stem Cell Therapy for Neurological Disorders Players in 2022
    Table 12. World Placental Stem Cell Therapy for Neurological Disorders Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Placental Stem Cell Therapy for Neurological Disorders Company Evaluation Quadrant
    Table 14. Head Office of Key Placental Stem Cell Therapy for Neurological Disorders Player
    Table 15. Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Type Footprint
    Table 16. Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Application Footprint
    Table 17. Placental Stem Cell Therapy for Neurological Disorders Mergers & Acquisitions Activity
    Table 18. United States VS China Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Placental Stem Cell Therapy for Neurological Disorders Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Placental Stem Cell Therapy for Neurological Disorders Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share (2018-2023)
    Table 23. China Based Placental Stem Cell Therapy for Neurological Disorders Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Placental Stem Cell Therapy for Neurological Disorders Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share (2018-2023)
    Table 29. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2024-2029) & (USD Million)
    Table 35. Mesoblast Basic Information, Area Served and Competitors
    Table 36. Mesoblast Major Business
    Table 37. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 38. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Mesoblast Recent Developments/Updates
    Table 40. Mesoblast Competitive Strengths & Weaknesses
    Table 41. Pleurite Therapeutic Basic Information, Area Served and Competitors
    Table 42. Pleurite Therapeutic Major Business
    Table 43. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 44. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Pleurite Therapeutic Recent Developments/Updates
    Table 46. Pleurite Therapeutic Competitive Strengths & Weaknesses
    Table 47. Athersys Basic Information, Area Served and Competitors
    Table 48. Athersys Major Business
    Table 49. Athersys Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 50. Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Athersys Recent Developments/Updates
    Table 52. Athersys Competitive Strengths & Weaknesses
    Table 53. Cordlife India Basic Information, Area Served and Competitors
    Table 54. Cordlife India Major Business
    Table 55. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 56. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Cordlife India Recent Developments/Updates
    Table 58. Cordlife India Competitive Strengths & Weaknesses
    Table 59. Life Cell Basic Information, Area Served and Competitors
    Table 60. Life Cell Major Business
    Table 61. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 62. Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Life Cell Recent Developments/Updates
    Table 64. Life Cell Competitive Strengths & Weaknesses
    Table 65. Cryo-Cell Basic Information, Area Served and Competitors
    Table 66. Cryo-Cell Major Business
    Table 67. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 68. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Cryo-Cell Recent Developments/Updates
    Table 70. Cryo-Cell Competitive Strengths & Weaknesses
    Table 71. CBR Systems Basic Information, Area Served and Competitors
    Table 72. CBR Systems Major Business
    Table 73. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 74. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. CBR Systems Recent Developments/Updates
    Table 76. CBR Systems Competitive Strengths & Weaknesses
    Table 77. ReNeuron Group Basic Information, Area Served and Competitors
    Table 78. ReNeuron Group Major Business
    Table 79. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 80. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. ReNeuron Group Recent Developments/Updates
    Table 82. ReNeuron Group Competitive Strengths & Weaknesses
    Table 83. Cynata Basic Information, Area Served and Competitors
    Table 84. Cynata Major Business
    Table 85. Cynata Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 86. Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Cynata Recent Developments/Updates
    Table 88. Cynata Competitive Strengths & Weaknesses
    Table 89. Celularity Basic Information, Area Served and Competitors
    Table 90. Celularity Major Business
    Table 91. Celularity Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 92. Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Celularity Recent Developments/Updates
    Table 94. Celularity Competitive Strengths & Weaknesses
    Table 95. Americord Registry Basic Information, Area Served and Competitors
    Table 96. Americord Registry Major Business
    Table 97. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 98. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Americord Registry Recent Developments/Updates
    Table 100. Americord Registry Competitive Strengths & Weaknesses
    Table 101. ReeLabs Basic Information, Area Served and Competitors
    Table 102. ReeLabs Major Business
    Table 103. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 104. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. ReeLabs Recent Developments/Updates
    Table 106. Mesoblast Basic Information, Area Served and Competitors
    Table 107. Mesoblast Major Business
    Table 108. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Services
    Table 109. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders Upstream (Raw Materials)
    Table 111. Placental Stem Cell Therapy for Neurological Disorders Typical Customers
List of Figure
    Figure 1. Placental Stem Cell Therapy for Neurological Disorders Picture
    Figure 2. World Placental Stem Cell Therapy for Neurological Disorders Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Placental Stem Cell Therapy for Neurological Disorders Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Placental Stem Cell Therapy for Neurological Disorders Revenue (2018-2029) & (USD Million)
    Figure 13. Placental Stem Cell Therapy for Neurological Disorders Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Placental Stem Cell Therapy for Neurological Disorders by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Placental Stem Cell Therapy for Neurological Disorders Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Placental Stem Cell Therapy for Neurological Disorders Markets in 2022
    Figure 27. United States VS China: Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type in 2022
    Figure 31. Allogeneic Placental Stem Cell Therapy
    Figure 32. Autologous Placental Stem Cell Therapy
    Figure 33. World Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2018-2029)
    Figure 34. World Placental Stem Cell Therapy for Neurological Disorders Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application in 2022
    Figure 36. Hospitals and Specialist Clinics
    Figure 37. Clinical Research Institute
    Figure 38. Placental Stem Cell Therapy for Neurological Disorders Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Companies Mentioned

Mesoblast
Pleurite Therapeutic
Athersys
Cordlife India
Life Cell
Cryo-Cell
CBR Systems
ReNeuron Group
Cynata
Celularity
Americord Registry
ReeLabs
Mesoblast